TL;DR
This paper challenges the "bigger is better" mantra for single-cell transcriptomics foundation models, finding that scaling up pre-training data doesn't always lead to better downstream performance. Instead, architectural improvements that enhance predictive diversity and biological plausibility are crucial for advancing the field.
What Problem Does This Paper Address?
The field of single-cell transcriptomics is increasingly leveraging "foundation models" – large, pre-trained models that learn generalizable representations from vast datasets. These models hold promise for simplifying complex downstream analyses like cell type classification and understanding cellular responses. However, two key questions have remained:
- Does simply increasing the amount of pre-training data (scaling) reliably improve model performance on various single-cell tasks?
- Do models trained on "rank-ordered" gene expression profiles (like Geneformer) offer an advantage in dealing with "batch effects" – technical variations that can obscure biological signals?
The authors aim to provide empirical evidence to answer these questions and guide future development in this rapidly evolving area.
Methods
The study systematically evaluates transformer-based models, primarily focusing on the Geneformer (GF) architecture, which represents gene expression as ranked sequences. They investigate two main aspects:
- Scaling: They compare models pre-trained on datasets of different sizes (1 million vs. 30 million single-cell profiles).
- Architectural Refinements: They introduce and evaluate a modified architecture called GFCAB (Geneformer with Cumulative-assignment on the prediction Adjustment and Boosting on the similarity-based diversity). This model incorporates two key mechanisms:
- Cumulative Prediction Adjustment: Aims to reduce redundancy in gene predictions within a single cell profile.
- Similarity-Based Regularization: Encourages the model to predict a more diverse set of genes, moving beyond a bias towards frequently expressed genes.
The models are evaluated on pre-training objectives (masked gene prediction accuracy, repetition, and uniqueness) and a suite of downstream tasks including cell type classification and zero-shot batch-effect mitigation.
Datasets
The study utilizes several datasets for training and evaluation:
- Pre-training:
- Genecorpus-30M: A large dataset of approximately 30 million ranked single-cell transcriptomic profiles.
- Genecorpus-1M: A smaller dataset created by randomly sampling 1 million profiles from Genecorpus-30M.
- Downstream Evaluation:
- Classification Tasks:
- Gene dosage-sensitivity classification (using data from Theodoris et al. [6]).
- Classification Tasks:
- Tissue-specific cell type classification (using data from Theodoris et al. [6]).
- Cardiomyocyte disease-state classification (using data from Chaffin et al. [24]).
- Zero-Shot Batch-Effect Mitigation Tasks: * Immune 330K dataset.
- Pancreas 16K dataset.
- PBMC 12K dataset.
- scCello OOD cell type 487K dataset.
Key Insights and Ideas
- "Bigger is not always better": Scaling up pre-training data improved masked gene prediction accuracy but didn't consistently translate to better performance on downstream tasks like classification or batch correction.
- Diminishing returns from scale: Smaller models often matched or even outperformed larger ones, suggesting that the benefits of increased data size plateau or even decrease beyond a certain point.
- Rank-based models struggle with batch effects: Models trained on rank-ordered profiles, while useful for other tasks, did not inherently offer advantages for mitigating batch effects and often underperformed specialized methods.
- Architectural innovation is key: The proposed GFCAB architecture, with its focus on cumulative prediction adjustment and similarity-based regularization, demonstrated improved predictive diversity and better performance, especially on smaller datasets, without relying solely on massive data scales.
- Diversity matters: High redundancy in predicted genes remains a significant limitation in current models, hindering biological interpretability. Enhancing predictive diversity is a critical area for future progress.
Key Results
- Pre-training: Models trained on smaller datasets (1M profiles) showed significantly higher prediction diversity (uniqueness) and lower repetition compared to models trained on larger datasets (30M profiles), while requiring substantially less computational resources (e.g., ~7.8% of resources for 1M vs. 30M).
- Classification: For classification tasks, models pre-trained on larger datasets (30M) generally performed better, highlighting the benefit of scale for fine-grained discrimination. However, GFCAB-1M achieved performance comparable to GF-30M in several benchmarks, demonstrating the power of architectural design.
- Batch-Effect Mitigation: Scaling pre-training data did not improve batch-effect mitigation performance; in fact, smaller models often performed better. GFCAB showed marked improvements in this area compared to GF, narrowing the gap with specialized domain-specific methods like scVI, though still trailing them.
- Ablation Study: Both cumulative prediction adjustment and similarity-based regularization in GFCAB contributed to improved diversity and performance, with GFCAB (combining both) showing the strongest results, particularly in batch-effect evaluations.
Limitations and Future Work
- Batch Correction Limitations: Despite architectural improvements, GFCAB and GF still underperformed compared to domain-specific methods like scVI for batch correction. This suggests that rank-based normalization alone is insufficient for robust batch handling, and future models may need representations explicitly designed for cross-batch alignment.
- Generalizability: The study focused on specific architectures and datasets. Further research is needed to explore whether these findings generalize across other single-cell modalities and tissues.
- Future Directions: The authors suggest pursuing hybrid strategies that combine rank-based modeling with batch-sensitive objectives, exploring multimodal integration, and investigating the interplay between scale and architecture across different biological contexts. They emphasize that future progress will likely hinge on architectures and objectives that faithfully represent the statistical and biological properties of single-cell data, rather than solely on increasing data scale.
Summary updated